48,589
edits
m (→Complement: wikify) |
(→Anti-MPO antibodies: fix ref.) |
||
Line 41: | Line 41: | ||
===Anti-MPO antibodies=== | ===Anti-MPO antibodies=== | ||
*MPO-ANCA associated with crescentic glomerulonephritis.<ref name=pmid10088959>PMID 10088959 | *MPO-ANCA associated with crescentic glomerulonephritis.<ref name=pmid10088959>{{Cite journal | last1 = Arahata | first1 = H. | last2 = Migita | first2 = K. | last3 = Izumoto | first3 = H. | last4 = Miyashita | first4 = T. | last5 = Munakata | first5 = H. | last6 = Nakamura | first6 = H. | last7 = Tominaga | first7 = M. | last8 = Origuchi | first8 = T. | last9 = Kawabe | first9 = Y. | title = Successful treatment of rapidly progressive lupus nephritis associated with anti-MPO antibodies by intravenous immunoglobulins. | journal = Clin Rheumatol | volume = 18 | issue = 1 | pages = 77-81 | month = | year = 1999 | doi = | PMID = 10088959 }} | ||
</ref> | |||
===C4d=== | ===C4d=== |
edits